|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.15 USD | +0.71% |
|
+2.46% | +28.18% |
| Dec. 03 | Pacira Biosciences reports inducement grants under Nasdaq Listing Rule | RE |
| Dec. 02 | Pacira Says Iovera Outperformed Radiofrequency Ablation in Chronic Low Back Pain | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.71% | +2.46% | +10.53% | -8.70% | +28.18% | +29.35% | -48.34% | -59.76% | -61.19% | 1.03B | |
| -0.68% | -6.21% | +8.95% | +38.71% | +30.66% | +22.17% | +173.14% | +584.22% | +1,067.72% | 908B | |
| -0.09% | -2.32% | +8.66% | +13.27% | +39.75% | +35.17% | +13.05% | +35.67% | +95.62% | 488B | |
| -0.82% | -0.64% | +4.37% | +6.44% | +27.32% | +28.43% | +38.01% | +113.77% | +302.08% | 404B | |
| +0.26% | +1.14% | +17.28% | +13.38% | +21.68% | +21.30% | +0.44% | +2.12% | +13.30% | 331B | |
| +0.58% | -2.73% | +9.17% | +12.42% | +29.84% | +28.01% | +20.71% | +68.41% | +203.16% | 280B | |
| +0.19% | +2.49% | +5.41% | +2.98% | +20.72% | +18.48% | +24.80% | +31.71% | +24.87% | 256B | |
| -0.92% | -4.55% | +18.57% | +18.12% | +0.58% | -3.37% | -9.05% | +21.27% | +86.40% | 250B | |
| +1.24% | -2.33% | +2.84% | -11.54% | -50.40% | -59.84% | -31.25% | +47.78% | +56.40% | 212B | |
| -2.20% | -3.82% | +3.88% | +17.15% | +27.48% | +21.12% | +16.62% | +46.73% | +109.90% | 183B | |
| -0.98% | -3.54% | -0.98% | +5.50% | +31.41% | +29.97% | +37.96% | +99.54% | +17.95% | 152B | |
| +1.15% | +0.96% | +5.60% | +4.45% | -2.04% | +1.12% | -48.77% | -37.00% | -20.43% | 146B | |
| +0.51% | -0.89% | -0.27% | +6.92% | -9.32% | -7.41% | -1.09% | +2.63% | +6.01% | 120B | |
| -0.27% | +5.16% | +9.35% | +15.12% | +13.24% | -0.85% | +43.58% | +100.83% | +274.41% | 116B | |
| +0.82% | +6.36% | +12.61% | +11.01% | -7.48% | -11.06% | -35.15% | -14.49% | -23.98% | 106B | |
| -1.15% | +0.78% | +0.95% | +22.29% | +34.05% | +34.55% | +26.92% | +3.31% | +9.10% | 97.85B | |
| -2.82% | -2.29% | +18.49% | +25.12% | +17.63% | +21.65% | +130.62% | +66.96% | +485.98% | 90.09B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -1.74% | +1.21% | +5.09% | +1.04% | +94.08% | +81.37% | +101.90% | +260.15% | +367.36% | 61.48B | |
| +0.60% | -0.76% | -0.48% | -10.24% | +34.25% | +24.74% | +52.15% | -19.03% | +289.62% | 57.56B | |
| Average | -0.31% | -0.28% | +7.37% | +9.65% | +20.09% | +16.57% | +26.64% | +71.31% | +173.91% | 216.23B | |
| Weighted average by Cap. | -0.35% | -2.18% | +8.18% | +15.79% | +21.22% | +17.15% | +49.03% | +161.33% | +322.36% |
- Stock Market
- Equities
- PCRX Stock
- Sector Pacira BioSciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
